Some good news.
A study out [recently] shows that an experimental treatment for Marburg virus – a close cousin to Ebola – can be given after symptoms of the terrible disease have started to appear.
One experimental drug – given to two Americans and several Liberians who showed signs of the disease – appears to have been helpful, though it is not clear whether the victims would have survived anyway or what other treatments they received. The drug, ZMapp, includes proteins that interfere with the way Ebola attaches and enters a host cell.
[Wednesday]‘s study, published in Science Translational Medicine, looks at a different drug that takes a genetic approach to fighting the disease. The drug uses bits of genetic material to block Ebola genes from acting, the way sticking gum in a lock would prevent a key from slipping in.
The research team from the University of Texas Medical Branch-Galveston and Canadian drug company Tekmira Pharmaceuticals injected the Marburg virus into four groups of four rhesus monkeys. The first group got the drug 30-45 minutes after infection; the second one day after infection; the third two days later; and the last group three days later. All of the treated animals lived, regardless of when they received the drug.
Although the study was on the Marburg virus, not Ebola, senior researcher Thomas Geisbert said he thinks the results mean that a related Ebola treatment, called TKM-Ebola, will also work once symptoms appear.
As we know, the Galveston National Lab is where the action is for Ebola research in the US. I don’t have anything to add here, I’m just glad to see them make things happen.